DexCom
DXCM
592 hedge funds and large institutions have $24.6B invested in DexCom in 2020 Q1 according to their latest regulatory filings, with 146 funds opening new positions, 195 increasing their positions, 191 reducing their positions, and 54 closing their positions.
170% more first-time investments, than exits
New positions opened: 146 | Existing positions closed: 54
50% more funds holding in top 10
Funds holding in top 10: 12 → 18 (+6)
24% more capital invested
Capital invested by funds: $19.9B → $24.6B (+$4.69B)
16% more funds holding
Funds holding: 509 → 592 (+83)
1.17% more ownership
Funds ownership: 397.73% → 398.9% (+1.2%)
2% more repeat investments, than reductions
Existing positions increased: 195 | Existing positions reduced: 191
26% less call options, than puts
Call options by funds: $134M | Put options by funds: $181M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$439M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
+$124M |
| 3 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$116M |
| 4 |
BlackRock
New York
|
+$113M |
| 5 |
Neuberger Berman Group
New York
|
+$84.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$412M |
| 2 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$232M |
| 3 |
Jennison Associates
New York
|
-$190M |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$130M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$124M |
DXCM Hedge Fund Activity: Q1 2020 in Review
592 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q1 2020, worth a combined $24.6B — up 24% from $19.9B a quarter earlier.
Buyers outnumbered sellers: 146 funds opened new DXCM positions and 54 closed out — a net gain of 92 holders — while 195 added to existing stakes and 191 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $439M. The largest seller was Capital World Investors, cutting an estimated $412M.
- 592 institutional investors held DexCom (DXCM) as of Q1 2020, up from 509 in Q4 2019.
- Funds reported $24.6B of DexCom stock for Q1 2020, up 24% quarter-over-quarter.
- 146 funds opened new DexCom positions in Q1 2020 and 54 closed out, a net change of +92 holders.
- The largest DexCom buyer in Q1 2020 was Fidelity Investments, an estimated $439M added.
- The largest DexCom seller in Q1 2020 was Capital World Investors, an estimated $412M sold.
Based on aggregated 13F filings for Q1 2020.